Company / Operating Cash Flow
Indivior Operating Cash Flow History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$27.0M
FY2025
5-year range
-$300.0M / $36.0M
FY2022-FY2025
Trend
-175.0%
vs FY2024
Sector context
#86 of 216
Health Care
What the data says
At -$27M, Indivior's operating cash flow ranks #86 of 216 in the Health Care sector. Improved from -$300M to -$27M over the past 2 years.
Based on SEC 10-K filings.
-$27M in FY2025.
Improved from -$300M to -$27M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#86 of 216 in Health CareTop 40% of 216This company -$27.0M Sector average $658.7M
▼
-104.1% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow decreased 175.0% year-over-year.
- Ranks #86 out of 216 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$27.0M | -175.0% |
| FY2024 | $36.0M | +112.0% |
| FY2023 | -$300.0M | -7400.0% |
| FY2022 | -$4.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026